nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—UGT2B7—Epirubicin—stomach cancer	0.0757	0.122	CbGbCtD
Lovastatin—UGT1A1—Irinotecan—stomach cancer	0.0636	0.102	CbGbCtD
Lovastatin—ABCB1—Mitomycin—stomach cancer	0.0492	0.079	CbGbCtD
Lovastatin—SLCO1B1—Irinotecan—stomach cancer	0.0441	0.0707	CbGbCtD
Lovastatin—ABCC2—Irinotecan—stomach cancer	0.0387	0.0622	CbGbCtD
Lovastatin—ABCC2—Docetaxel—stomach cancer	0.0284	0.0456	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.0258	0.0415	CbGbCtD
Lovastatin—CYP3A7—Irinotecan—stomach cancer	0.0258	0.0415	CbGbCtD
Lovastatin—SLCO1A2—Methotrexate—stomach cancer	0.0247	0.0397	CbGbCtD
Lovastatin—SLCO1B1—Methotrexate—stomach cancer	0.0233	0.0374	CbGbCtD
Lovastatin—ABCC2—Doxorubicin—stomach cancer	0.0211	0.034	CbGbCtD
Lovastatin—CYP2C9—Capecitabine—stomach cancer	0.021	0.0338	CbGbCtD
Lovastatin—ABCC2—Methotrexate—stomach cancer	0.0205	0.0329	CbGbCtD
Lovastatin—CYP3A5—Irinotecan—stomach cancer	0.0194	0.0311	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.0189	0.0304	CbGbCtD
Lovastatin—CYP3A7—Docetaxel—stomach cancer	0.0189	0.0304	CbGbCtD
Lovastatin—CYP2C8—Fluorouracil—stomach cancer	0.0179	0.0287	CbGbCtD
Lovastatin—CYP3A5—Docetaxel—stomach cancer	0.0142	0.0228	CbGbCtD
Lovastatin—ABCB1—Irinotecan—stomach cancer	0.0126	0.0203	CbGbCtD
Lovastatin—CYP2C9—Fluorouracil—stomach cancer	0.0125	0.02	CbGbCtD
Lovastatin—ABCB1—Docetaxel—stomach cancer	0.00925	0.0148	CbGbCtD
Lovastatin—CYP3A4—Irinotecan—stomach cancer	0.00756	0.0121	CbGbCtD
Lovastatin—ABCB1—Doxorubicin—stomach cancer	0.00689	0.0111	CbGbCtD
Lovastatin—ABCB1—Methotrexate—stomach cancer	0.00668	0.0107	CbGbCtD
Lovastatin—ITGAL—blood vessel—stomach cancer	0.00659	0.0674	CbGeAlD
Lovastatin—CYP2D6—Doxorubicin—stomach cancer	0.0065	0.0104	CbGbCtD
Lovastatin—ABCC2—bile—stomach cancer	0.00586	0.0598	CbGeAlD
Lovastatin—CYP3A4—Docetaxel—stomach cancer	0.00554	0.0089	CbGbCtD
Lovastatin—CYP3A4—Doxorubicin—stomach cancer	0.00413	0.00663	CbGbCtD
Lovastatin—ITGAL—hematopoietic system—stomach cancer	0.00351	0.0359	CbGeAlD
Lovastatin—HDAC2—Topotecan—Irinotecan—stomach cancer	0.00347	1	CbGdCrCtD
Lovastatin—ITGAL—epithelium—stomach cancer	0.00321	0.0328	CbGeAlD
Lovastatin—PON3—pancreas—stomach cancer	0.0028	0.0287	CbGeAlD
Lovastatin—ITGAL—lymphoid tissue—stomach cancer	0.00247	0.0253	CbGeAlD
Lovastatin—ITGAL—digestive system—stomach cancer	0.00244	0.025	CbGeAlD
Lovastatin—ITGAL—bone marrow—stomach cancer	0.00225	0.023	CbGeAlD
Lovastatin—HMGCR—gall bladder—stomach cancer	0.00224	0.0229	CbGeAlD
Lovastatin—PON3—bone marrow—stomach cancer	0.00221	0.0226	CbGeAlD
Lovastatin—UGT1A3—digestive system—stomach cancer	0.00208	0.0212	CbGeAlD
Lovastatin—ITGAL—endocrine gland—stomach cancer	0.00202	0.0206	CbGeAlD
Lovastatin—PON3—endocrine gland—stomach cancer	0.00198	0.0202	CbGeAlD
Lovastatin—ITGAL—liver—stomach cancer	0.00182	0.0186	CbGeAlD
Lovastatin—PON3—liver—stomach cancer	0.00178	0.0182	CbGeAlD
Lovastatin—UGT1A3—endocrine gland—stomach cancer	0.00172	0.0175	CbGeAlD
Lovastatin—UGT1A3—liver—stomach cancer	0.00155	0.0158	CbGeAlD
Lovastatin—UGT1A1—hematopoietic system—stomach cancer	0.00146	0.0149	CbGeAlD
Lovastatin—HDAC2—hematopoietic system—stomach cancer	0.0014	0.0143	CbGeAlD
Lovastatin—ITGAL—lymph node—stomach cancer	0.00139	0.0143	CbGeAlD
Lovastatin—HDAC2—epithelium—stomach cancer	0.00128	0.0131	CbGeAlD
Lovastatin—HMGCR—hematopoietic system—stomach cancer	0.00127	0.0129	CbGeAlD
Lovastatin—HDAC2—smooth muscle tissue—stomach cancer	0.00124	0.0126	CbGeAlD
Lovastatin—SLCO1B1—hematopoietic system—stomach cancer	0.00121	0.0124	CbGeAlD
Lovastatin—UGT2B7—digestive system—stomach cancer	0.00119	0.0122	CbGeAlD
Lovastatin—HMGCR—epithelium—stomach cancer	0.00116	0.0118	CbGeAlD
Lovastatin—HDAC2—pancreas—stomach cancer	0.00114	0.0117	CbGeAlD
Lovastatin—HMGCR—smooth muscle tissue—stomach cancer	0.00112	0.0114	CbGeAlD
Lovastatin—HMGCR—pancreas—stomach cancer	0.00103	0.0105	CbGeAlD
Lovastatin—CYP3A7—endocrine gland—stomach cancer	0.00102	0.0104	CbGeAlD
Lovastatin—UGT1A1—digestive system—stomach cancer	0.00101	0.0104	CbGeAlD
Lovastatin—HDAC2—lymphoid tissue—stomach cancer	0.000988	0.0101	CbGeAlD
Lovastatin—SLCO1A2—hematopoietic system—stomach cancer	0.000987	0.0101	CbGeAlD
Lovastatin—UGT2B7—endocrine gland—stomach cancer	0.000985	0.0101	CbGeAlD
Lovastatin—HDAC2—digestive system—stomach cancer	0.000976	0.00998	CbGeAlD
Lovastatin—CYP3A7—liver—stomach cancer	0.000917	0.00937	CbGeAlD
Lovastatin—HDAC2—bone marrow—stomach cancer	0.0009	0.0092	CbGeAlD
Lovastatin—HMGCR—lymphoid tissue—stomach cancer	0.000892	0.00911	CbGeAlD
Lovastatin—UGT2B7—liver—stomach cancer	0.000888	0.00908	CbGeAlD
Lovastatin—HMGCR—digestive system—stomach cancer	0.000881	0.009	CbGeAlD
Lovastatin—SLCO1B1—digestive system—stomach cancer	0.000844	0.00862	CbGeAlD
Lovastatin—UGT1A1—endocrine gland—stomach cancer	0.000838	0.00856	CbGeAlD
Lovastatin—HMGCR—bone marrow—stomach cancer	0.000812	0.0083	CbGeAlD
Lovastatin—HDAC2—endocrine gland—stomach cancer	0.000807	0.00824	CbGeAlD
Lovastatin—CYP2C19—hematopoietic system—stomach cancer	0.00079	0.00808	CbGeAlD
Lovastatin—CYP3A7-CYP3A51P—liver—stomach cancer	0.000779	0.00797	CbGeAlD
Lovastatin—UGT1A1—liver—stomach cancer	0.000755	0.00772	CbGeAlD
Lovastatin—HMGCR—endocrine gland—stomach cancer	0.000728	0.00744	CbGeAlD
Lovastatin—HDAC2—liver—stomach cancer	0.000727	0.00743	CbGeAlD
Lovastatin—SLCO1B1—endocrine gland—stomach cancer	0.000697	0.00713	CbGeAlD
Lovastatin—CYP2C8—hematopoietic system—stomach cancer	0.00069	0.00705	CbGeAlD
Lovastatin—SLCO1A2—digestive system—stomach cancer	0.000687	0.00702	CbGeAlD
Lovastatin—HMGCR—liver—stomach cancer	0.000656	0.00671	CbGeAlD
Lovastatin—ABCC2—digestive system—stomach cancer	0.00064	0.00654	CbGeAlD
Lovastatin—SLCO1B1—liver—stomach cancer	0.000629	0.00642	CbGeAlD
Lovastatin—CYP3A5—hematopoietic system—stomach cancer	0.000623	0.00636	CbGeAlD
Lovastatin—ABCB1—blood vessel—stomach cancer	0.000621	0.00635	CbGeAlD
Lovastatin—CYP2C9—hematopoietic system—stomach cancer	0.000613	0.00626	CbGeAlD
Lovastatin—SLCO1A2—endocrine gland—stomach cancer	0.000567	0.0058	CbGeAlD
Lovastatin—HDAC2—lymph node—stomach cancer	0.000558	0.0057	CbGeAlD
Lovastatin—CYP2C19—digestive system—stomach cancer	0.00055	0.00562	CbGeAlD
Lovastatin—ABCC2—endocrine gland—stomach cancer	0.000529	0.0054	CbGeAlD
Lovastatin—SLCO1A2—liver—stomach cancer	0.000512	0.00523	CbGeAlD
Lovastatin—CYP3A5—pancreas—stomach cancer	0.000507	0.00518	CbGeAlD
Lovastatin—HMGCR—lymph node—stomach cancer	0.000503	0.00514	CbGeAlD
Lovastatin—ABCC2—liver—stomach cancer	0.000477	0.00487	CbGeAlD
Lovastatin—CYP3A4—hematopoietic system—stomach cancer	0.000467	0.00478	CbGeAlD
Lovastatin—CYP2D6—hematopoietic system—stomach cancer	0.00046	0.0047	CbGeAlD
Lovastatin—CYP2C19—endocrine gland—stomach cancer	0.000454	0.00464	CbGeAlD
Lovastatin—CYP3A5—digestive system—stomach cancer	0.000433	0.00443	CbGeAlD
Lovastatin—CYP2C9—digestive system—stomach cancer	0.000426	0.00436	CbGeAlD
Lovastatin—CYP2C19—liver—stomach cancer	0.00041	0.00419	CbGeAlD
Lovastatin—CYP2C8—endocrine gland—stomach cancer	0.000396	0.00405	CbGeAlD
Lovastatin—ABCC2—lymph node—stomach cancer	0.000365	0.00373	CbGeAlD
Lovastatin—CYP3A5—endocrine gland—stomach cancer	0.000358	0.00366	CbGeAlD
Lovastatin—CYP2C8—liver—stomach cancer	0.000357	0.00365	CbGeAlD
Lovastatin—CYP2C9—endocrine gland—stomach cancer	0.000352	0.0036	CbGeAlD
Lovastatin—ABCB1—hematopoietic system—stomach cancer	0.000331	0.00338	CbGeAlD
Lovastatin—CYP3A4—digestive system—stomach cancer	0.000325	0.00332	CbGeAlD
Lovastatin—CYP3A5—liver—stomach cancer	0.000323	0.0033	CbGeAlD
Lovastatin—CYP2D6—digestive system—stomach cancer	0.00032	0.00327	CbGeAlD
Lovastatin—CYP2C9—liver—stomach cancer	0.000317	0.00324	CbGeAlD
Lovastatin—ABCB1—epithelium—stomach cancer	0.000302	0.00309	CbGeAlD
Lovastatin—ABCB1—pancreas—stomach cancer	0.000269	0.00275	CbGeAlD
Lovastatin—CYP3A4—endocrine gland—stomach cancer	0.000269	0.00274	CbGeAlD
Lovastatin—CYP2D6—endocrine gland—stomach cancer	0.000264	0.0027	CbGeAlD
Lovastatin—CYP3A4—liver—stomach cancer	0.000242	0.00247	CbGeAlD
Lovastatin—CYP2D6—liver—stomach cancer	0.000238	0.00243	CbGeAlD
Lovastatin—ABCB1—lymphoid tissue—stomach cancer	0.000233	0.00238	CbGeAlD
Lovastatin—ABCB1—digestive system—stomach cancer	0.00023	0.00235	CbGeAlD
Lovastatin—ABCB1—bone marrow—stomach cancer	0.000212	0.00217	CbGeAlD
Lovastatin—Feeling abnormal—Fluorouracil—stomach cancer	0.000209	0.00163	CcSEcCtD
Lovastatin—Muscle spasms—Capecitabine—stomach cancer	0.000209	0.00163	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.000205	0.0016	CcSEcCtD
Lovastatin—Vision blurred—Capecitabine—stomach cancer	0.000204	0.0016	CcSEcCtD
Lovastatin—Tremor—Capecitabine—stomach cancer	0.000203	0.00159	CcSEcCtD
Lovastatin—Ill-defined disorder—Capecitabine—stomach cancer	0.000201	0.00158	CcSEcCtD
Lovastatin—Urticaria—Fluorouracil—stomach cancer	0.000201	0.00158	CcSEcCtD
Lovastatin—Influenza—Doxorubicin—stomach cancer	0.000201	0.00157	CcSEcCtD
Lovastatin—Leukopenia—Docetaxel—stomach cancer	0.000201	0.00157	CcSEcCtD
Lovastatin—Body temperature increased—Fluorouracil—stomach cancer	0.0002	0.00157	CcSEcCtD
Lovastatin—Eosinophilia—Doxorubicin—stomach cancer	0.000199	0.00156	CcSEcCtD
Lovastatin—Photosensitivity reaction—Epirubicin—stomach cancer	0.000198	0.00155	CcSEcCtD
Lovastatin—Pancreatitis—Doxorubicin—stomach cancer	0.000197	0.00154	CcSEcCtD
Lovastatin—Malaise—Capecitabine—stomach cancer	0.000196	0.00153	CcSEcCtD
Lovastatin—Vertigo—Capecitabine—stomach cancer	0.000195	0.00153	CcSEcCtD
Lovastatin—Hypersensitivity—Irinotecan—stomach cancer	0.000195	0.00153	CcSEcCtD
Lovastatin—Leukopenia—Capecitabine—stomach cancer	0.000194	0.00152	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000192	0.0015	CcSEcCtD
Lovastatin—Myalgia—Docetaxel—stomach cancer	0.000191	0.00149	CcSEcCtD
Lovastatin—Chest pain—Docetaxel—stomach cancer	0.000191	0.00149	CcSEcCtD
Lovastatin—Arthralgia—Docetaxel—stomach cancer	0.000191	0.00149	CcSEcCtD
Lovastatin—ABCB1—endocrine gland—stomach cancer	0.00019	0.00194	CbGeAlD
Lovastatin—Asthenia—Irinotecan—stomach cancer	0.00019	0.00149	CcSEcCtD
Lovastatin—Neuropathy peripheral—Epirubicin—stomach cancer	0.00019	0.00148	CcSEcCtD
Lovastatin—Urinary tract infection—Epirubicin—stomach cancer	0.000188	0.00147	CcSEcCtD
Lovastatin—Hypersensitivity—Fluorouracil—stomach cancer	0.000187	0.00146	CcSEcCtD
Lovastatin—Dry mouth—Docetaxel—stomach cancer	0.000187	0.00146	CcSEcCtD
Lovastatin—Hepatitis—Methotrexate—stomach cancer	0.000186	0.00145	CcSEcCtD
Lovastatin—Chest pain—Capecitabine—stomach cancer	0.000185	0.00145	CcSEcCtD
Lovastatin—Myalgia—Capecitabine—stomach cancer	0.000185	0.00145	CcSEcCtD
Lovastatin—Arthralgia—Capecitabine—stomach cancer	0.000185	0.00145	CcSEcCtD
Lovastatin—Confusional state—Docetaxel—stomach cancer	0.000184	0.00144	CcSEcCtD
Lovastatin—Anxiety—Capecitabine—stomach cancer	0.000184	0.00144	CcSEcCtD
Lovastatin—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000183	0.00143	CcSEcCtD
Lovastatin—Anaphylactic shock—Docetaxel—stomach cancer	0.000183	0.00143	CcSEcCtD
Lovastatin—Discomfort—Capecitabine—stomach cancer	0.000183	0.00143	CcSEcCtD
Lovastatin—Infection—Docetaxel—stomach cancer	0.000182	0.00142	CcSEcCtD
Lovastatin—Sinusitis—Epirubicin—stomach cancer	0.000181	0.00142	CcSEcCtD
Lovastatin—Diarrhoea—Irinotecan—stomach cancer	0.000181	0.00142	CcSEcCtD
Lovastatin—Dry mouth—Capecitabine—stomach cancer	0.000181	0.00141	CcSEcCtD
Lovastatin—Pruritus—Fluorouracil—stomach cancer	0.000179	0.0014	CcSEcCtD
Lovastatin—Thrombocytopenia—Docetaxel—stomach cancer	0.000179	0.0014	CcSEcCtD
Lovastatin—Confusional state—Capecitabine—stomach cancer	0.000179	0.0014	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000177	0.00139	CcSEcCtD
Lovastatin—Infection—Capecitabine—stomach cancer	0.000176	0.00138	CcSEcCtD
Lovastatin—Erythema multiforme—Methotrexate—stomach cancer	0.000175	0.00137	CcSEcCtD
Lovastatin—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000175	0.00137	CcSEcCtD
Lovastatin—Dizziness—Irinotecan—stomach cancer	0.000175	0.00137	CcSEcCtD
Lovastatin—Anorexia—Docetaxel—stomach cancer	0.000174	0.00136	CcSEcCtD
Lovastatin—Urinary tract infection—Doxorubicin—stomach cancer	0.000174	0.00136	CcSEcCtD
Lovastatin—Hepatitis—Epirubicin—stomach cancer	0.000174	0.00136	CcSEcCtD
Lovastatin—Diarrhoea—Fluorouracil—stomach cancer	0.000173	0.00136	CcSEcCtD
Lovastatin—Thrombocytopenia—Capecitabine—stomach cancer	0.000173	0.00136	CcSEcCtD
Lovastatin—ABCB1—liver—stomach cancer	0.000171	0.00175	CbGeAlD
Lovastatin—Anorexia—Capecitabine—stomach cancer	0.000169	0.00132	CcSEcCtD
Lovastatin—Vomiting—Irinotecan—stomach cancer	0.000168	0.00132	CcSEcCtD
Lovastatin—Sinusitis—Doxorubicin—stomach cancer	0.000168	0.00131	CcSEcCtD
Lovastatin—Dizziness—Fluorouracil—stomach cancer	0.000168	0.00131	CcSEcCtD
Lovastatin—Rash—Irinotecan—stomach cancer	0.000167	0.00131	CcSEcCtD
Lovastatin—Dermatitis—Irinotecan—stomach cancer	0.000167	0.0013	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000167	0.0013	CcSEcCtD
Lovastatin—Chills—Methotrexate—stomach cancer	0.000166	0.0013	CcSEcCtD
Lovastatin—Headache—Irinotecan—stomach cancer	0.000166	0.0013	CcSEcCtD
Lovastatin—Insomnia—Docetaxel—stomach cancer	0.000165	0.00129	CcSEcCtD
Lovastatin—Paraesthesia—Docetaxel—stomach cancer	0.000164	0.00129	CcSEcCtD
Lovastatin—Erythema multiforme—Epirubicin—stomach cancer	0.000164	0.00129	CcSEcCtD
Lovastatin—Alopecia—Methotrexate—stomach cancer	0.000164	0.00128	CcSEcCtD
Lovastatin—Dyspnoea—Docetaxel—stomach cancer	0.000163	0.00128	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000161	0.00126	CcSEcCtD
Lovastatin—Flushing—Epirubicin—stomach cancer	0.000161	0.00126	CcSEcCtD
Lovastatin—Vomiting—Fluorouracil—stomach cancer	0.000161	0.00126	CcSEcCtD
Lovastatin—Dyspepsia—Docetaxel—stomach cancer	0.000161	0.00126	CcSEcCtD
Lovastatin—Hepatitis—Doxorubicin—stomach cancer	0.000161	0.00126	CcSEcCtD
Lovastatin—Insomnia—Capecitabine—stomach cancer	0.00016	0.00125	CcSEcCtD
Lovastatin—Rash—Fluorouracil—stomach cancer	0.00016	0.00125	CcSEcCtD
Lovastatin—Dermatitis—Fluorouracil—stomach cancer	0.00016	0.00125	CcSEcCtD
Lovastatin—Paraesthesia—Capecitabine—stomach cancer	0.000159	0.00124	CcSEcCtD
Lovastatin—Decreased appetite—Docetaxel—stomach cancer	0.000159	0.00124	CcSEcCtD
Lovastatin—Headache—Fluorouracil—stomach cancer	0.000159	0.00124	CcSEcCtD
Lovastatin—Dysgeusia—Methotrexate—stomach cancer	0.000158	0.00124	CcSEcCtD
Lovastatin—Dyspnoea—Capecitabine—stomach cancer	0.000158	0.00124	CcSEcCtD
Lovastatin—Fatigue—Docetaxel—stomach cancer	0.000158	0.00123	CcSEcCtD
Lovastatin—Nausea—Irinotecan—stomach cancer	0.000157	0.00123	CcSEcCtD
Lovastatin—Pain—Docetaxel—stomach cancer	0.000156	0.00122	CcSEcCtD
Lovastatin—Constipation—Docetaxel—stomach cancer	0.000156	0.00122	CcSEcCtD
Lovastatin—Back pain—Methotrexate—stomach cancer	0.000156	0.00122	CcSEcCtD
Lovastatin—Dyspepsia—Capecitabine—stomach cancer	0.000156	0.00122	CcSEcCtD
Lovastatin—Chills—Epirubicin—stomach cancer	0.000156	0.00122	CcSEcCtD
Lovastatin—Decreased appetite—Capecitabine—stomach cancer	0.000154	0.0012	CcSEcCtD
Lovastatin—Alopecia—Epirubicin—stomach cancer	0.000153	0.0012	CcSEcCtD
Lovastatin—Fatigue—Capecitabine—stomach cancer	0.000153	0.0012	CcSEcCtD
Lovastatin—Vision blurred—Methotrexate—stomach cancer	0.000152	0.00119	CcSEcCtD
Lovastatin—Erythema multiforme—Doxorubicin—stomach cancer	0.000152	0.00119	CcSEcCtD
Lovastatin—Constipation—Capecitabine—stomach cancer	0.000151	0.00119	CcSEcCtD
Lovastatin—Pain—Capecitabine—stomach cancer	0.000151	0.00119	CcSEcCtD
Lovastatin—Feeling abnormal—Docetaxel—stomach cancer	0.000151	0.00118	CcSEcCtD
Lovastatin—Nausea—Fluorouracil—stomach cancer	0.000151	0.00118	CcSEcCtD
Lovastatin—Ill-defined disorder—Methotrexate—stomach cancer	0.00015	0.00117	CcSEcCtD
Lovastatin—Gastrointestinal pain—Docetaxel—stomach cancer	0.00015	0.00117	CcSEcCtD
Lovastatin—Flushing—Doxorubicin—stomach cancer	0.000149	0.00117	CcSEcCtD
Lovastatin—Flatulence—Epirubicin—stomach cancer	0.000149	0.00117	CcSEcCtD
Lovastatin—Dysgeusia—Epirubicin—stomach cancer	0.000148	0.00116	CcSEcCtD
Lovastatin—Back pain—Epirubicin—stomach cancer	0.000146	0.00114	CcSEcCtD
Lovastatin—Feeling abnormal—Capecitabine—stomach cancer	0.000146	0.00114	CcSEcCtD
Lovastatin—Malaise—Methotrexate—stomach cancer	0.000146	0.00114	CcSEcCtD
Lovastatin—Muscle spasms—Epirubicin—stomach cancer	0.000145	0.00114	CcSEcCtD
Lovastatin—Vertigo—Methotrexate—stomach cancer	0.000145	0.00114	CcSEcCtD
Lovastatin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000145	0.00113	CcSEcCtD
Lovastatin—Body temperature increased—Docetaxel—stomach cancer	0.000145	0.00113	CcSEcCtD
Lovastatin—Abdominal pain—Docetaxel—stomach cancer	0.000145	0.00113	CcSEcCtD
Lovastatin—Leukopenia—Methotrexate—stomach cancer	0.000145	0.00113	CcSEcCtD
Lovastatin—Chills—Doxorubicin—stomach cancer	0.000144	0.00113	CcSEcCtD
Lovastatin—Vision blurred—Epirubicin—stomach cancer	0.000142	0.00112	CcSEcCtD
Lovastatin—Alopecia—Doxorubicin—stomach cancer	0.000142	0.00111	CcSEcCtD
Lovastatin—Urticaria—Capecitabine—stomach cancer	0.000141	0.0011	CcSEcCtD
Lovastatin—Ill-defined disorder—Epirubicin—stomach cancer	0.00014	0.0011	CcSEcCtD
Lovastatin—Body temperature increased—Capecitabine—stomach cancer	0.00014	0.0011	CcSEcCtD
Lovastatin—Abdominal pain—Capecitabine—stomach cancer	0.00014	0.0011	CcSEcCtD
Lovastatin—Flatulence—Doxorubicin—stomach cancer	0.000138	0.00108	CcSEcCtD
Lovastatin—Chest pain—Methotrexate—stomach cancer	0.000138	0.00108	CcSEcCtD
Lovastatin—Arthralgia—Methotrexate—stomach cancer	0.000138	0.00108	CcSEcCtD
Lovastatin—Myalgia—Methotrexate—stomach cancer	0.000138	0.00108	CcSEcCtD
Lovastatin—Dysgeusia—Doxorubicin—stomach cancer	0.000137	0.00107	CcSEcCtD
Lovastatin—Malaise—Epirubicin—stomach cancer	0.000136	0.00107	CcSEcCtD
Lovastatin—Discomfort—Methotrexate—stomach cancer	0.000136	0.00106	CcSEcCtD
Lovastatin—Vertigo—Epirubicin—stomach cancer	0.000136	0.00106	CcSEcCtD
Lovastatin—Leukopenia—Epirubicin—stomach cancer	0.000135	0.00106	CcSEcCtD
Lovastatin—Back pain—Doxorubicin—stomach cancer	0.000135	0.00106	CcSEcCtD
Lovastatin—Hypersensitivity—Docetaxel—stomach cancer	0.000135	0.00105	CcSEcCtD
Lovastatin—Muscle spasms—Doxorubicin—stomach cancer	0.000134	0.00105	CcSEcCtD
Lovastatin—Confusional state—Methotrexate—stomach cancer	0.000133	0.00104	CcSEcCtD
Lovastatin—Anaphylactic shock—Methotrexate—stomach cancer	0.000132	0.00103	CcSEcCtD
Lovastatin—Vision blurred—Doxorubicin—stomach cancer	0.000132	0.00103	CcSEcCtD
Lovastatin—ABCB1—lymph node—stomach cancer	0.000131	0.00134	CbGeAlD
Lovastatin—Asthenia—Docetaxel—stomach cancer	0.000131	0.00103	CcSEcCtD
Lovastatin—Infection—Methotrexate—stomach cancer	0.000131	0.00103	CcSEcCtD
Lovastatin—Hypersensitivity—Capecitabine—stomach cancer	0.00013	0.00102	CcSEcCtD
Lovastatin—Ill-defined disorder—Doxorubicin—stomach cancer	0.00013	0.00102	CcSEcCtD
Lovastatin—Pruritus—Docetaxel—stomach cancer	0.000129	0.00101	CcSEcCtD
Lovastatin—Thrombocytopenia—Methotrexate—stomach cancer	0.000129	0.00101	CcSEcCtD
Lovastatin—Chest pain—Epirubicin—stomach cancer	0.000129	0.00101	CcSEcCtD
Lovastatin—Arthralgia—Epirubicin—stomach cancer	0.000129	0.00101	CcSEcCtD
Lovastatin—Myalgia—Epirubicin—stomach cancer	0.000129	0.00101	CcSEcCtD
Lovastatin—Anxiety—Epirubicin—stomach cancer	0.000128	0.001	CcSEcCtD
Lovastatin—Discomfort—Epirubicin—stomach cancer	0.000127	0.000995	CcSEcCtD
Lovastatin—Asthenia—Capecitabine—stomach cancer	0.000127	0.000995	CcSEcCtD
Lovastatin—Malaise—Doxorubicin—stomach cancer	0.000126	0.000987	CcSEcCtD
Lovastatin—Dry mouth—Epirubicin—stomach cancer	0.000126	0.000985	CcSEcCtD
Lovastatin—Vertigo—Doxorubicin—stomach cancer	0.000126	0.000984	CcSEcCtD
Lovastatin—Anorexia—Methotrexate—stomach cancer	0.000126	0.000984	CcSEcCtD
Lovastatin—Pruritus—Capecitabine—stomach cancer	0.000125	0.000981	CcSEcCtD
Lovastatin—Leukopenia—Doxorubicin—stomach cancer	0.000125	0.00098	CcSEcCtD
Lovastatin—Diarrhoea—Docetaxel—stomach cancer	0.000125	0.00098	CcSEcCtD
Lovastatin—Confusional state—Epirubicin—stomach cancer	0.000124	0.000974	CcSEcCtD
Lovastatin—Anaphylactic shock—Epirubicin—stomach cancer	0.000123	0.000966	CcSEcCtD
Lovastatin—Infection—Epirubicin—stomach cancer	0.000123	0.000959	CcSEcCtD
Lovastatin—Diarrhoea—Capecitabine—stomach cancer	0.000121	0.000948	CcSEcCtD
Lovastatin—Dizziness—Docetaxel—stomach cancer	0.000121	0.000947	CcSEcCtD
Lovastatin—Thrombocytopenia—Epirubicin—stomach cancer	0.000121	0.000945	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.00012	0.00094	CcSEcCtD
Lovastatin—Insomnia—Methotrexate—stomach cancer	0.000119	0.000933	CcSEcCtD
Lovastatin—Myalgia—Doxorubicin—stomach cancer	0.000119	0.000932	CcSEcCtD
Lovastatin—Chest pain—Doxorubicin—stomach cancer	0.000119	0.000932	CcSEcCtD
Lovastatin—Arthralgia—Doxorubicin—stomach cancer	0.000119	0.000932	CcSEcCtD
Lovastatin—Anxiety—Doxorubicin—stomach cancer	0.000119	0.000929	CcSEcCtD
Lovastatin—Paraesthesia—Methotrexate—stomach cancer	0.000118	0.000927	CcSEcCtD
Lovastatin—Discomfort—Doxorubicin—stomach cancer	0.000118	0.000921	CcSEcCtD
Lovastatin—Anorexia—Epirubicin—stomach cancer	0.000118	0.00092	CcSEcCtD
Lovastatin—Dyspnoea—Methotrexate—stomach cancer	0.000118	0.00092	CcSEcCtD
Lovastatin—Dizziness—Capecitabine—stomach cancer	0.000117	0.000917	CcSEcCtD
Lovastatin—Dry mouth—Doxorubicin—stomach cancer	0.000116	0.000912	CcSEcCtD
Lovastatin—Vomiting—Docetaxel—stomach cancer	0.000116	0.00091	CcSEcCtD
Lovastatin—Dyspepsia—Methotrexate—stomach cancer	0.000116	0.000908	CcSEcCtD
Lovastatin—Rash—Docetaxel—stomach cancer	0.000115	0.000903	CcSEcCtD
Lovastatin—Dermatitis—Docetaxel—stomach cancer	0.000115	0.000902	CcSEcCtD
Lovastatin—Confusional state—Doxorubicin—stomach cancer	0.000115	0.000901	CcSEcCtD
Lovastatin—Decreased appetite—Methotrexate—stomach cancer	0.000115	0.000897	CcSEcCtD
Lovastatin—Headache—Docetaxel—stomach cancer	0.000115	0.000897	CcSEcCtD
Lovastatin—Anaphylactic shock—Doxorubicin—stomach cancer	0.000114	0.000893	CcSEcCtD
Lovastatin—Fatigue—Methotrexate—stomach cancer	0.000114	0.00089	CcSEcCtD
Lovastatin—Infection—Doxorubicin—stomach cancer	0.000113	0.000888	CcSEcCtD
Lovastatin—Pain—Methotrexate—stomach cancer	0.000113	0.000882	CcSEcCtD
Lovastatin—Vomiting—Capecitabine—stomach cancer	0.000113	0.000881	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000112	0.00088	CcSEcCtD
Lovastatin—Thrombocytopenia—Doxorubicin—stomach cancer	0.000112	0.000875	CcSEcCtD
Lovastatin—Rash—Capecitabine—stomach cancer	0.000112	0.000874	CcSEcCtD
Lovastatin—Insomnia—Epirubicin—stomach cancer	0.000112	0.000873	CcSEcCtD
Lovastatin—Dermatitis—Capecitabine—stomach cancer	0.000112	0.000873	CcSEcCtD
Lovastatin—Headache—Capecitabine—stomach cancer	0.000111	0.000868	CcSEcCtD
Lovastatin—Paraesthesia—Epirubicin—stomach cancer	0.000111	0.000867	CcSEcCtD
Lovastatin—Dyspnoea—Epirubicin—stomach cancer	0.00011	0.000861	CcSEcCtD
Lovastatin—Anorexia—Doxorubicin—stomach cancer	0.000109	0.000852	CcSEcCtD
Lovastatin—Nausea—Docetaxel—stomach cancer	0.000109	0.00085	CcSEcCtD
Lovastatin—Feeling abnormal—Methotrexate—stomach cancer	0.000109	0.00085	CcSEcCtD
Lovastatin—Dyspepsia—Epirubicin—stomach cancer	0.000109	0.00085	CcSEcCtD
Lovastatin—Gastrointestinal pain—Methotrexate—stomach cancer	0.000108	0.000844	CcSEcCtD
Lovastatin—Decreased appetite—Epirubicin—stomach cancer	0.000107	0.000839	CcSEcCtD
Lovastatin—Fatigue—Epirubicin—stomach cancer	0.000106	0.000833	CcSEcCtD
Lovastatin—Pain—Epirubicin—stomach cancer	0.000106	0.000826	CcSEcCtD
Lovastatin—Constipation—Epirubicin—stomach cancer	0.000106	0.000826	CcSEcCtD
Lovastatin—Nausea—Capecitabine—stomach cancer	0.000105	0.000823	CcSEcCtD
Lovastatin—Urticaria—Methotrexate—stomach cancer	0.000105	0.00082	CcSEcCtD
Lovastatin—Abdominal pain—Methotrexate—stomach cancer	0.000104	0.000816	CcSEcCtD
Lovastatin—Body temperature increased—Methotrexate—stomach cancer	0.000104	0.000816	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000104	0.000814	CcSEcCtD
Lovastatin—Insomnia—Doxorubicin—stomach cancer	0.000103	0.000808	CcSEcCtD
Lovastatin—Paraesthesia—Doxorubicin—stomach cancer	0.000103	0.000802	CcSEcCtD
Lovastatin—Dyspnoea—Doxorubicin—stomach cancer	0.000102	0.000797	CcSEcCtD
Lovastatin—Feeling abnormal—Epirubicin—stomach cancer	0.000102	0.000796	CcSEcCtD
Lovastatin—Gastrointestinal pain—Epirubicin—stomach cancer	0.000101	0.00079	CcSEcCtD
Lovastatin—Dyspepsia—Doxorubicin—stomach cancer	0.0001	0.000787	CcSEcCtD
Lovastatin—Decreased appetite—Doxorubicin—stomach cancer	9.92e-05	0.000777	CcSEcCtD
Lovastatin—Fatigue—Doxorubicin—stomach cancer	9.84e-05	0.00077	CcSEcCtD
Lovastatin—Urticaria—Epirubicin—stomach cancer	9.8e-05	0.000767	CcSEcCtD
Lovastatin—Pain—Doxorubicin—stomach cancer	9.76e-05	0.000764	CcSEcCtD
Lovastatin—Constipation—Doxorubicin—stomach cancer	9.76e-05	0.000764	CcSEcCtD
Lovastatin—Body temperature increased—Epirubicin—stomach cancer	9.75e-05	0.000763	CcSEcCtD
Lovastatin—Abdominal pain—Epirubicin—stomach cancer	9.75e-05	0.000763	CcSEcCtD
Lovastatin—Hypersensitivity—Methotrexate—stomach cancer	9.71e-05	0.00076	CcSEcCtD
Lovastatin—Asthenia—Methotrexate—stomach cancer	9.46e-05	0.00074	CcSEcCtD
Lovastatin—Feeling abnormal—Doxorubicin—stomach cancer	9.41e-05	0.000736	CcSEcCtD
Lovastatin—Gastrointestinal pain—Doxorubicin—stomach cancer	9.33e-05	0.000731	CcSEcCtD
Lovastatin—Pruritus—Methotrexate—stomach cancer	9.33e-05	0.00073	CcSEcCtD
Lovastatin—Hypersensitivity—Epirubicin—stomach cancer	9.09e-05	0.000711	CcSEcCtD
Lovastatin—Urticaria—Doxorubicin—stomach cancer	9.07e-05	0.00071	CcSEcCtD
Lovastatin—Abdominal pain—Doxorubicin—stomach cancer	9.02e-05	0.000706	CcSEcCtD
Lovastatin—Body temperature increased—Doxorubicin—stomach cancer	9.02e-05	0.000706	CcSEcCtD
Lovastatin—Diarrhoea—Methotrexate—stomach cancer	9.02e-05	0.000706	CcSEcCtD
Lovastatin—Asthenia—Epirubicin—stomach cancer	8.85e-05	0.000693	CcSEcCtD
Lovastatin—Pruritus—Epirubicin—stomach cancer	8.73e-05	0.000683	CcSEcCtD
Lovastatin—Dizziness—Methotrexate—stomach cancer	8.72e-05	0.000682	CcSEcCtD
Lovastatin—Diarrhoea—Epirubicin—stomach cancer	8.44e-05	0.000661	CcSEcCtD
Lovastatin—Hypersensitivity—Doxorubicin—stomach cancer	8.41e-05	0.000658	CcSEcCtD
Lovastatin—Vomiting—Methotrexate—stomach cancer	8.38e-05	0.000656	CcSEcCtD
Lovastatin—Rash—Methotrexate—stomach cancer	8.31e-05	0.000651	CcSEcCtD
Lovastatin—Dermatitis—Methotrexate—stomach cancer	8.3e-05	0.00065	CcSEcCtD
Lovastatin—Headache—Methotrexate—stomach cancer	8.26e-05	0.000646	CcSEcCtD
Lovastatin—Asthenia—Doxorubicin—stomach cancer	8.19e-05	0.000641	CcSEcCtD
Lovastatin—Dizziness—Epirubicin—stomach cancer	8.16e-05	0.000639	CcSEcCtD
Lovastatin—Pruritus—Doxorubicin—stomach cancer	8.08e-05	0.000632	CcSEcCtD
Lovastatin—Vomiting—Epirubicin—stomach cancer	7.84e-05	0.000614	CcSEcCtD
Lovastatin—Nausea—Methotrexate—stomach cancer	7.83e-05	0.000613	CcSEcCtD
Lovastatin—Diarrhoea—Doxorubicin—stomach cancer	7.81e-05	0.000611	CcSEcCtD
Lovastatin—Rash—Epirubicin—stomach cancer	7.78e-05	0.000609	CcSEcCtD
Lovastatin—Dermatitis—Epirubicin—stomach cancer	7.77e-05	0.000608	CcSEcCtD
Lovastatin—Headache—Epirubicin—stomach cancer	7.73e-05	0.000605	CcSEcCtD
Lovastatin—Dizziness—Doxorubicin—stomach cancer	7.55e-05	0.000591	CcSEcCtD
Lovastatin—Nausea—Epirubicin—stomach cancer	7.33e-05	0.000574	CcSEcCtD
Lovastatin—Vomiting—Doxorubicin—stomach cancer	7.26e-05	0.000568	CcSEcCtD
Lovastatin—Rash—Doxorubicin—stomach cancer	7.2e-05	0.000563	CcSEcCtD
Lovastatin—Dermatitis—Doxorubicin—stomach cancer	7.19e-05	0.000563	CcSEcCtD
Lovastatin—Headache—Doxorubicin—stomach cancer	7.15e-05	0.00056	CcSEcCtD
Lovastatin—Nausea—Doxorubicin—stomach cancer	6.78e-05	0.000531	CcSEcCtD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	8.38e-06	5.66e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	8.36e-06	5.64e-05	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	8.33e-06	5.63e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—TYMS—stomach cancer	8.29e-06	5.59e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ALOX5—stomach cancer	8.26e-06	5.58e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	8.25e-06	5.57e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GSTM1—stomach cancer	8.19e-06	5.53e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ALDOB—stomach cancer	8.17e-06	5.52e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CDKN1A—stomach cancer	8.14e-06	5.49e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PLIN2—stomach cancer	8.13e-06	5.49e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	8.13e-06	5.49e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—DPYD—stomach cancer	8.13e-06	5.49e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ALDOB—stomach cancer	8.1e-06	5.47e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ALOX5—stomach cancer	8.06e-06	5.44e-05	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	8.06e-06	5.44e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTT1—stomach cancer	8.05e-06	5.44e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL6R—stomach cancer	7.97e-06	5.38e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP2A6—stomach cancer	7.96e-06	5.37e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTGS2—stomach cancer	7.95e-06	5.37e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CAV1—stomach cancer	7.94e-06	5.36e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—DPYD—stomach cancer	7.93e-06	5.36e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—APOA1—stomach cancer	7.92e-06	5.35e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CA2—stomach cancer	7.91e-06	5.34e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—MTHFR—stomach cancer	7.89e-06	5.33e-05	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	7.76e-06	5.24e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AKR1C3—stomach cancer	7.74e-06	5.23e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CD44—stomach cancer	7.73e-06	5.22e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ALB—stomach cancer	7.73e-06	5.21e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NT5E—stomach cancer	7.71e-06	5.2e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PGAM1—stomach cancer	7.71e-06	5.2e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ERCC2—stomach cancer	7.7e-06	5.2e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	7.64e-06	5.16e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	7.62e-06	5.15e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ALOX5—stomach cancer	7.6e-06	5.13e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ENO1—stomach cancer	7.55e-06	5.09e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ALOX5—stomach cancer	7.53e-06	5.09e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PPARG—stomach cancer	7.48e-06	5.05e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—DPYD—stomach cancer	7.48e-06	5.05e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MAPK3—stomach cancer	7.47e-06	5.04e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SERPINE1—stomach cancer	7.46e-06	5.04e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	7.42e-06	5.01e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—DPYD—stomach cancer	7.41e-06	5e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—NOS3—stomach cancer	7.39e-06	4.99e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	7.37e-06	4.97e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALDH7A1—stomach cancer	7.36e-06	4.97e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PLCE1—stomach cancer	7.36e-06	4.97e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CAV1—stomach cancer	7.28e-06	4.91e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MYC—stomach cancer	7.27e-06	4.9e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—APOA1—stomach cancer	7.26e-06	4.9e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—STAT3—stomach cancer	7.26e-06	4.9e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—MTHFR—stomach cancer	7.24e-06	4.89e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RHOA—stomach cancer	7.2e-06	4.86e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTT1—stomach cancer	7.19e-06	4.85e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NOS3—stomach cancer	7.13e-06	4.81e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP2A6—stomach cancer	7.11e-06	4.8e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—UMPS—stomach cancer	7.05e-06	4.76e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTT1—stomach cancer	7.02e-06	4.74e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PPARG—stomach cancer	6.98e-06	4.71e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.95e-06	4.69e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MAPK3—stomach cancer	6.94e-06	4.68e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP2A6—stomach cancer	6.94e-06	4.68e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AKR1C3—stomach cancer	6.91e-06	4.67e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTGS2—stomach cancer	6.76e-06	4.56e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AKR1C3—stomach cancer	6.75e-06	4.55e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MYC—stomach cancer	6.75e-06	4.55e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ENO1—stomach cancer	6.74e-06	4.55e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ALB—stomach cancer	6.73e-06	4.54e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	6.72e-06	4.53e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CD44—stomach cancer	6.69e-06	4.52e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CAV1—stomach cancer	6.68e-06	4.51e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ERBB2—stomach cancer	6.67e-06	4.5e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—APOA1—stomach cancer	6.66e-06	4.5e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.63e-06	4.47e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTT1—stomach cancer	6.61e-06	4.46e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MAPK1—stomach cancer	6.6e-06	4.45e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—EGFR—stomach cancer	6.6e-06	4.45e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ENO1—stomach cancer	6.57e-06	4.44e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PPP2R1A—stomach cancer	6.57e-06	4.43e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PDHA1—stomach cancer	6.56e-06	4.43e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ECHS1—stomach cancer	6.56e-06	4.43e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTT1—stomach cancer	6.55e-06	4.42e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP2A6—stomach cancer	6.54e-06	4.41e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.49e-06	4.38e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP2A6—stomach cancer	6.48e-06	4.37e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GSTP1—stomach cancer	6.44e-06	4.35e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—NOS3—stomach cancer	6.43e-06	4.34e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PPARG—stomach cancer	6.4e-06	4.32e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AKR1C3—stomach cancer	6.36e-06	4.29e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—HMOX1—stomach cancer	6.36e-06	4.29e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCL8—stomach cancer	6.32e-06	4.27e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AKR1C3—stomach cancer	6.3e-06	4.25e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ALB—stomach cancer	6.28e-06	4.24e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—KRAS—stomach cancer	6.23e-06	4.21e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ENO1—stomach cancer	6.2e-06	4.18e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CDKN1B—stomach cancer	6.17e-06	4.17e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TYMP—stomach cancer	6.16e-06	4.16e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—FADS1—stomach cancer	6.16e-06	4.16e-05	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	6.15e-06	4.15e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ENO1—stomach cancer	6.14e-06	4.15e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.04e-06	4.08e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—NOS3—stomach cancer	6e-06	4.05e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PIK3CA—stomach cancer	6e-06	4.05e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—TYMS—stomach cancer	5.99e-06	4.04e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CD44—stomach cancer	5.97e-06	4.03e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GSTM1—stomach cancer	5.92e-06	4e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCND1—stomach cancer	5.89e-06	3.98e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTGS2—stomach cancer	5.89e-06	3.97e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—JUN—stomach cancer	5.88e-06	3.97e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PPARG—stomach cancer	5.87e-06	3.96e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CD44—stomach cancer	5.83e-06	3.94e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.8e-06	3.91e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SREBF2—stomach cancer	5.77e-06	3.9e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ALB—stomach cancer	5.75e-06	3.88e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PIK3CA—stomach cancer	5.73e-06	3.87e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MMP9—stomach cancer	5.72e-06	3.86e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—RORA—stomach cancer	5.7e-06	3.85e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CDKN1A—stomach cancer	5.7e-06	3.85e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PPP2R1A—stomach cancer	5.69e-06	3.84e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTP1—stomach cancer	5.58e-06	3.77e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ERCC2—stomach cancer	5.57e-06	3.76e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAPK8—stomach cancer	5.56e-06	3.75e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—HMOX1—stomach cancer	5.51e-06	3.72e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—NOS3—stomach cancer	5.5e-06	3.71e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CD44—stomach cancer	5.49e-06	3.71e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTGS2—stomach cancer	5.49e-06	3.71e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CD44—stomach cancer	5.45e-06	3.68e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALDOB—stomach cancer	5.34e-06	3.61e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HRAS—stomach cancer	5.3e-06	3.58e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.28e-06	3.57e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ALB—stomach cancer	5.28e-06	3.56e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—MTHFR—stomach cancer	5.23e-06	3.53e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—TYMS—stomach cancer	5.19e-06	3.5e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VEGFA—stomach cancer	5.13e-06	3.47e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTM1—stomach cancer	5.13e-06	3.46e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—STAT3—stomach cancer	5.08e-06	3.43e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PPP2R1A—stomach cancer	5.08e-06	3.43e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IL6—stomach cancer	5.07e-06	3.42e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—NOS3—stomach cancer	5.05e-06	3.41e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTGS2—stomach cancer	5.03e-06	3.4e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTP1—stomach cancer	4.98e-06	3.36e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALOX5—stomach cancer	4.97e-06	3.35e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PPP2R1A—stomach cancer	4.96e-06	3.35e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—HMOX1—stomach cancer	4.91e-06	3.32e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PIK3CA—stomach cancer	4.89e-06	3.3e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—DPYD—stomach cancer	4.89e-06	3.3e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTP1—stomach cancer	4.86e-06	3.28e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAPK3—stomach cancer	4.86e-06	3.28e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CAV1—stomach cancer	4.83e-06	3.26e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ERCC2—stomach cancer	4.82e-06	3.26e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—APOA1—stomach cancer	4.82e-06	3.25e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—HMOX1—stomach cancer	4.8e-06	3.24e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MYC—stomach cancer	4.72e-06	3.19e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PPP2R1A—stomach cancer	4.67e-06	3.15e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—TYMS—stomach cancer	4.63e-06	3.13e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PPP2R1A—stomach cancer	4.63e-06	3.13e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAPK1—stomach cancer	4.62e-06	3.12e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EGFR—stomach cancer	4.62e-06	3.12e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTGS2—stomach cancer	4.62e-06	3.12e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTP1—stomach cancer	4.58e-06	3.09e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTM1—stomach cancer	4.58e-06	3.09e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTP1—stomach cancer	4.54e-06	3.07e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—MTHFR—stomach cancer	4.53e-06	3.06e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—TYMS—stomach cancer	4.52e-06	3.05e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—HMOX1—stomach cancer	4.52e-06	3.05e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—HMOX1—stomach cancer	4.48e-06	3.02e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTM1—stomach cancer	4.47e-06	3.02e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KRAS—stomach cancer	4.36e-06	2.95e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTT1—stomach cancer	4.32e-06	2.92e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ERCC2—stomach cancer	4.3e-06	2.91e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP2A6—stomach cancer	4.27e-06	2.88e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TYMS—stomach cancer	4.26e-06	2.88e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PPARG—stomach cancer	4.24e-06	2.86e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TYMS—stomach cancer	4.22e-06	2.85e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTM1—stomach cancer	4.21e-06	2.84e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ERCC2—stomach cancer	4.2e-06	2.84e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CAV1—stomach cancer	4.18e-06	2.82e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTM1—stomach cancer	4.17e-06	2.82e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—APOA1—stomach cancer	4.17e-06	2.82e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CA—stomach cancer	4.16e-06	2.81e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AKR1C3—stomach cancer	4.16e-06	2.81e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ENO1—stomach cancer	4.05e-06	2.73e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—MTHFR—stomach cancer	4.05e-06	2.73e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CA—stomach cancer	4.01e-06	2.71e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4e-06	2.7e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ERCC2—stomach cancer	3.96e-06	2.67e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—MTHFR—stomach cancer	3.95e-06	2.67e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ERCC2—stomach cancer	3.93e-06	2.65e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—stomach cancer	3.88e-06	2.62e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ALB—stomach cancer	3.82e-06	2.58e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CAV1—stomach cancer	3.73e-06	2.52e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—APOA1—stomach cancer	3.72e-06	2.51e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—MTHFR—stomach cancer	3.72e-06	2.51e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HRAS—stomach cancer	3.71e-06	2.5e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—MTHFR—stomach cancer	3.69e-06	2.49e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PPARG—stomach cancer	3.68e-06	2.48e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—NOS3—stomach cancer	3.65e-06	2.46e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CAV1—stomach cancer	3.64e-06	2.46e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APOA1—stomach cancer	3.63e-06	2.45e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CA—stomach cancer	3.62e-06	2.44e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CD44—stomach cancer	3.59e-06	2.42e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.57e-06	2.41e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL6—stomach cancer	3.55e-06	2.4e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CAV1—stomach cancer	3.43e-06	2.32e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APOA1—stomach cancer	3.43e-06	2.31e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CAV1—stomach cancer	3.4e-06	2.3e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APOA1—stomach cancer	3.4e-06	2.29e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CA—stomach cancer	3.38e-06	2.28e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS2—stomach cancer	3.34e-06	2.25e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ALB—stomach cancer	3.31e-06	2.23e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PPARG—stomach cancer	3.28e-06	2.21e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.25e-06	2.19e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PPARG—stomach cancer	3.2e-06	2.16e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—NOS3—stomach cancer	3.16e-06	2.13e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CA—stomach cancer	3.1e-06	2.09e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.05e-06	2.06e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PPARG—stomach cancer	3.02e-06	2.04e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTP1—stomach cancer	3e-06	2.02e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PPARG—stomach cancer	2.99e-06	2.02e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HMOX1—stomach cancer	2.95e-06	1.99e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ALB—stomach cancer	2.95e-06	1.99e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS2—stomach cancer	2.89e-06	1.95e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ALB—stomach cancer	2.88e-06	1.94e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CA—stomach cancer	2.84e-06	1.92e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—NOS3—stomach cancer	2.82e-06	1.91e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TYMS—stomach cancer	2.79e-06	1.88e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NOS3—stomach cancer	2.75e-06	1.86e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTM1—stomach cancer	2.75e-06	1.86e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ALB—stomach cancer	2.71e-06	1.83e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ALB—stomach cancer	2.69e-06	1.82e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NOS3—stomach cancer	2.6e-06	1.75e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ERCC2—stomach cancer	2.59e-06	1.75e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS2—stomach cancer	2.58e-06	1.74e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NOS3—stomach cancer	2.57e-06	1.74e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS2—stomach cancer	2.52e-06	1.7e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MTHFR—stomach cancer	2.43e-06	1.64e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS2—stomach cancer	2.37e-06	1.6e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS2—stomach cancer	2.35e-06	1.59e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CAV1—stomach cancer	2.24e-06	1.52e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOA1—stomach cancer	2.24e-06	1.51e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CA—stomach cancer	2.05e-06	1.39e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PPARG—stomach cancer	1.97e-06	1.33e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CA—stomach cancer	1.78e-06	1.2e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALB—stomach cancer	1.77e-06	1.2e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NOS3—stomach cancer	1.7e-06	1.15e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.59e-06	1.07e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS2—stomach cancer	1.55e-06	1.05e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CA—stomach cancer	1.55e-06	1.05e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.46e-06	9.86e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.45e-06	9.77e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CA—stomach cancer	9.55e-07	6.45e-06	CbGpPWpGaD
